Hydroxychloroquine/lopinavir/ritonavirLack of efficacy and off label use: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1908卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16002-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：274 / 274

相关论文

共 50 条

[41] Multiple drugsLack of efficacy and off-label use: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 328 - 328
[42] Multiple drugsLack of efficacy and off-label use: 3 case reports
Reactions Weekly, 2022, 1910 (1) : 317 - 317
[43] Lopinavir/ritonavir/tocilizumabHypertriglyceridaemia following off-label use: 2 case reports
Reactions Weekly, 2020, 1824 (1) : 180 - 180
[44] AdalimumabLack of efficacy and off-label use: case reports
Reactions Weekly, 2023, 1972 (1) : 19 - 19
[45] AntibacterialsLack of efficacy, off label use: 2 case reports
Reactions Weekly, 2021, 1878 (1) : 55 - 55
[46] BusulfanLack of efficacy and off label use: 2 case reports
Reactions Weekly, 2025, 2042 (1) : 94 - 94
[47] IvosidenibLack of efficacy and off label use: 5 case reports
Reactions Weekly, 2025, 2046 (1) : 211 - 211
[48] DexamethasoneLack of efficacy and off label use: 2 case reports
Reactions Weekly, 2022, 1911 (1) : 174 - 174
[49] FavipiravirLack of efficacy and off label use: 2 case reports
Reactions Weekly, 2022, 1933 (1) : 208 - 208
[50] PosaconazoleLack of efficacy and off label use: 5 case reports
Reactions Weekly, 2022, 1906 (1) : 332 - 332

← 1 2 3 4 5 →